PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas
{{output}}
Background/aims: The programmed cell death receptor 1 (PD-1) checkpoint inhibitor, nivolumab, has been approved for the treatment of metastatic renal cell carcinoma (RCC). However, the understanding of the expression and distribu... ...
